Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia
- PMID: 1449240
- DOI: 10.1002/ana.410320502
Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia
Abstract
Dopa-responsive dystonia (DRD) is one form of childhood-onset idiopathic torsion dystonia. Adult-onset parkinsonism has appeared in several previously unaffected members in families with DRD suggesting that this may be an additional phenotypical expression of the disease. We report a family with DRD in which 2 women and 1 man, unaffected by dystonia, developed tremor-onset parkinsonism after age 50 years. The women continue on a low dosage of levodopa after 9 and 13 years of treatment, with a stable, nearly complete, symptomatic response. This contrasts to the typical long-term treatment complications observed in patients with Parkinson's disease. We assessed nigrostriatal dopaminergic function in the proband, with typical DRD, and the 2 women with parkinsonism using 6-[18F]fluoro-L-dopa positron emission tomography. All 3 had normal striatal 6-[18F]fluoro-L-dopa uptake. These observations provide compelling evidence that "benign" adult-onset parkinsonism may be an expression of the disease in some members of families with DRD and does not support consideration of the DRD gene as a risk factor for development of Parkinson's disease. There may be considerable clinical heterogeneity in DRD depending on the age at onset.
Similar articles
-
Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.Ann Neurol. 1993 Nov;34(5):733-8. doi: 10.1002/ana.410340518. Ann Neurol. 1993. PMID: 8239569
-
Clinical heterogeneity of dopa-responsive dystonia: PET observations.Adv Neurol. 1993;60:586-90. Adv Neurol. 1993. PMID: 8420195
-
Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia.Neurology. 1993 Aug;43(8):1563-8. doi: 10.1212/wnl.43.8.1563. Neurology. 1993. PMID: 8351012
-
Contributions of positron emission tomography to elucidating the pathogenesis of idiopathic parkinsonism and dopa responsive dystonia.J Neural Transm Suppl. 1997;50:47-52. doi: 10.1007/978-3-7091-6842-4_6. J Neural Transm Suppl. 1997. PMID: 9120424 Review.
-
[PET study of dopamine metabolism and dopamine D2 receptor in juvenile parkinsonism].Nihon Rinsho. 1997 Jan;55(1):89-94. Nihon Rinsho. 1997. PMID: 9014428 Review. Japanese.
Cited by
-
Clinical and Genetic Heterogeneity in a Cohort of Chinese Children With Dopa-Responsive Dystonia.Front Pediatr. 2020 Feb 28;8:83. doi: 10.3389/fped.2020.00083. eCollection 2020. Front Pediatr. 2020. PMID: 32185155 Free PMC article.
-
Clinical spectrum of dopa-responsive dystonia and related disorders.Curr Neurol Neurosci Rep. 2014 Jul;14(7):461. doi: 10.1007/s11910-014-0461-9. Curr Neurol Neurosci Rep. 2014. PMID: 24844652 Free PMC article. Review.
-
Lessons from a remarkable family with dopa-responsive dystonia.J Neurol Neurosurg Psychiatry. 1994 Apr;57(4):460-3. doi: 10.1136/jnnp.57.4.460. J Neurol Neurosurg Psychiatry. 1994. PMID: 8163996 Free PMC article.
-
Clinical and Basic Research on Dopa-Responsive Dystonia: Neuropathological and Neurochemical Findings.Juntendo Med J. 2025 Jan 30;71(1):2-10. doi: 10.14789/ejmj.JMJ24-0023-R. eCollection 2025. Juntendo Med J. 2025. PMID: 40109402 Free PMC article.
-
Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.Brain. 2014 Sep;137(Pt 9):2480-92. doi: 10.1093/brain/awu179. Epub 2014 Jul 2. Brain. 2014. PMID: 24993959 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical